Answers are grounded in this paper and cite their sources.
Metabolic phenotyping reveals abnormal glucose tests in patients awaiting kidney transplants, suggesting improved screening strategies.
One-third of wait-listed patients without manifest diabetes exhibit abnormal OGTT. Age, fasting glucose, and statin use increase risk. Patients below age and fasting glucose thresholds, without statins, have low abnormal OGTT likelihood, potentially reducing routine testing. Annual OGTT may benefit patients initially with normal results, if overweight/obese, or on statins.
No takes yet. Share an insight, caveat, or question.
Terán-García et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: